We discovered that although BLNK, CD40 and CD210 were constitutively expressed across most subsets (Figure 4a), the overall expression of these markers by B cells was lower in patients with untreated MS compared with non‐MS controls (Figure 4b). The gene discussed is CD40; the disease is myeloid sarcoma.